Processing your payment...
Please do not close your browser.

Implantable Cardiac Monitors Market - Global Growth, Trends and Forecast (2022 - 2029) By Types, By Application, By Regions and By Key Players: Abbott Laboratories (NYSE: ABT), Edwards Life Science (NYSE: EW), Boston Scientific Co(NYSE: BSX)

24 Jun, 2022 | 162 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the next forecast years the Implantable Cardiac Monitors market will register a 5.79% CAGR in terms of revenue, the global market size will reach USD 37.9 Billion by 2029.

Implantable Cardiac Monitors Market Overview

Implantable Cardiac Monitors (ICM), also known as implantable loop recorders (ILR), are single-lead, subcutaneous electrocardiographic (ECG) monitoring devices used for diagnosis in patients with recurrent unexplained syncope or palpitations, for extended monitoring in patients at risk for or with atrial fibrillation (AF), and for risk stratification in patients who have had a myocardial infarction (MI) and those who have had a stroke.

The market is expected to be driven by technology advances and an increase in the global elderly population. Furthermore, increased stroke prevalence, adoption of and awareness of extended ECG monitoring of the heart rhythm, improvements in health care infrastructure, and increased demand for subcutaneous implanted cardiac monitors are all expected to boost the global implantable cardiac monitor market during the forecast period. In the next years, the global implantable cardiac monitor market is likely to be propelled by increased investments by key competitors through collaborations, mergers, and acquisitions, as well as increased demand for the development of tiny devices. The installation of cardiac monitors, on the other hand, is a time-consuming procedure.

With the advent of technology advancements in the healthcare industry, the acceptance rate of novel types of equipment and techniques to treat and monitor medical diseases that were previously untreatable has increased. Increased public awareness of the importance of taking preventive health measures, as well as increased investment in the healthcare sector, have fueled demand for cardiac monitoring devices and aided the market's growth.

What is our Implantable Cardiac Monitors Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029 CAGR

 

CAGR of 5.79% during the review period (2022 to 2029).

 

By Type

  • Cardiac Arrhythmias
  • Atrial Fibrillation
  • Epilepsy & Unexplained Falls

 

By Application

  • Hospitals
  • Cardiac Center & Clinics
  • Ambulatory Surgical Centers (ASCs)

 

 By Companies

 

 

 

 

Abbott Laboratories, Phoenix Heart PLLC, Biotronik, Edwards Life Science, GE Healthcare, Boston Scientific Co, Medtronic Plc, Koninklijke Philips (Philips Healthcare), Nihon Kohden Co, Livanova Plc (Sorin)

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Base Year

 

 

2022

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

162

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Who are the Major Players in Implantable Cardiac Monitors Market?

The Implantable Cardiac Monitors Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market Abbott Laboratories (NYSE: ABT), Phoenix Heart PLLC, Biotronik, Edwards Life Science (NYSE: EW), GE Healthcare, Boston Scientific Co(NYSE: BSX), Medtronic Plc (NYSE: MDT), Koninklijke Philips (Philips Healthcare), Nihon Kohden Co, Livanova Plc (Sorin) ,ZOLL Medical.

Industry News:

May 2020: Biotronik another leader in cardiac rhythm management had announced its new alliance with Acutus Medical to develop products of electrophysiology to treat cardiac arrhythmias across Europe and Asia.

On Jan 21, 2021, Boston Scientific Corporation announced its plans to acquire a privately-held company- Preventice Solutions Inc., which currently has a full portfolio of mobile cardiac health solutions and services with a wide range of products such as short and long-term Holter monitors, mobile cardiac telemetry and ambulatory cardiac monitors in the Implantable Cardiac Monitors market. Boston Scientific has been associated with Preventice Solutions since 2015 as an investor.

What are the major Applications, Types and Regions for Implantable Cardiac Monitors Market?

By Type, it is segmented into

  • Cardiac Arrhythmias
  •  Atrial Fibrillation
  •  Epilepsy & Unexplained Falls

By Applications it is segmented into

  • Hospitals
  • Cardiac Center & Clinics
  • Ambulatory Surgical Centers (ASCs)

Implantable Cardiac Monitors Market Regional Analysis

North America dominates the global market for mouth ulcer therapy due to technological improvements in the field of dentistry and rising demand for pharmaceutical products in the region, Furthermore, improved healthcare facilities and greater knowledge about oral health are propelling the market for mouth ulcer therapy in this region.

The market for Implantable Cardiac Monitors in Asia is predicted to increase rapidly over the next few years, followed by Europe. In Asia, China and India are likely to be the fastest expanding markets.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America

The Implantable Cardiac Monitors Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Implantable Cardiac Monitors Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
  4. Key Insights
    1. Pricing Analysis, By Key Regions, 2022
    2. Price Comparison (USD Per Ton) By Type (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy & Unexplained Falls) 2021/2022
    3. Price Comparison (USD, Per Ton): By Application (Hospitals, Cardiac Center & Clinics, Ambulatory Surgical Centers (ASCs)) 2021/2022
    4. Impact of COVID-19 on the Implantable Cardiac Monitors Market
    5. Production Share of Implantable Cardiac Monitors, By Region, 2022
    6. Key Industry Developments
  5. Global Implantable Cardiac Monitors Market Analysis, Insights and Forecast, 2022-2029
    1. Market Analysis, Insights and Forecast – By Application
      1. Hospitals
      2. Clinics
      3. Other
    2. Market Analysis, Insights and Forecast – By Type
      1. Cardiac Arrhythmias
      2. Atrial Fibrillation
      3. Epilepsy & Unexplained Falls
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Abbott Laboratories (NYSE: ABT)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Edwards Life Science (NYSE: EW)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Boston Scientific Co(NYSE: BSX)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Medtronic Plc (NYSE: MDT)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla